Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Axonics, Inc. | exhibit321.htm |
| EX-31.2 - EXHIBIT 31.2 - Axonics, Inc. | exhibit312.htm |
| EX-31.1 - EXHIBIT 31.1 - Axonics, Inc. | exhibit311.htm |
| 10-Q - 10-Q - Axonics, Inc. | axnx-09302018x10qdocument.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Axonics Modulation Technologies, Inc. (the "Company") on Form 10-Q for the quarterly period ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: December 11, 2018 | By: | /s/ Danny L. Dearen | |
Danny L. Dearen | |||
President and Chief Financial Officer | |||
(Principal Financial Officer) | |||